Trial
NCT00936832
Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery
Phase IIWITHDRAWNEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Federation Francophone de Cancerologie Digestive
Collaborators
—
Condition
Colorectal Cancer
Intervention
FOLFIRI regimen
Why stopped
because the sunitinib showed futility in anotehr trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-30